Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool March 6, 2008 Timothy M. Otte	Longs Drugs Has a Nice Niche West Coast regional drugstore chain scores solid fourth quarter.
The Motley Fool August 16, 2007 Lawrence Rothman	Longs' Prescription for Success Longs Drug Stores may be small, but it excels in its regional niche. Operating primarily on the West Coast, second-quarter results show a company with lots of room for growth.
The Motley Fool November 16, 2006 Matthew Crews	Medicare Benefits for Longs Drug Stores Part D benefit services generate sales for the retail pharmacy, but the store faces larger rivals. Investors, take note.
The Motley Fool March 24, 2008 Timothy M. Otte	Expecting More From Walgreen The drugstore giant has managed to beat analyst estimates two quarters in a row, but earnings are lagging sales growth, and growth is slowing too.
The Motley Fool June 18, 2007 Rich Duprey	Foolish Forecast: Walgreens Prescribes Growth The drugstore and convenience shop chain will report its third-quarter 2007 financial results shortly. Investors, here is what you can expect to see.
The Motley Fool January 3, 2005 Nathan Slaughter	Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground.
The Motley Fool June 26, 2007	A Generics Quarter at Walgreen: Fool by Numbers Soaring sales of generic drugs helped Walgreen's revenue reach a record $13.7 billion.
The Motley Fool March 26, 2007 Ryan Fuhrmann	A Healthy Shade of Walgreen: Fool by Numbers The drugstore chain released second-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool March 5, 2004 Dave Marino-Nachison	Longs Coming Up Short Investors who bid on a Longs buyout haven't been rewarded in recent months.
The Motley Fool February 12, 2004 Dave Marino-Nachison	CVS Bags Big 2003 A strong year for the drugstore giant has spilled into January.
The Motley Fool September 26, 2006 Ryan Fuhrmann	Jaw-Dropping Pill-Popping at Walgreen How much longer can investors count on Walgreen's stellar numbers?
The Motley Fool May 8, 2007 Ryan Fuhrmann	CVS/Caremark Tie the Knot While it's too early to see if CVS blazed a new health-care trail by combining a drugstore chain with giant pharmacy benefit manager Caremark, there are still interesting tidbits to pass along to investors from recently reported results.
The Motley Fool December 21, 2007 Timothy M. Otte	Walgreen Shapes Up for 2008 The drugstore chain reports lower expenses in the first quarter while pumping up sales.
The Motley Fool September 4, 2007 Ryan Fuhrmann	Foolish Forecast: Casey's Revs Its Earnings Engine The convenience store operator is set to release its first-quarter results. Investors, here is what you can expect to see.
The Motley Fool August 28, 2007 Lawrence A. Rothman	Foolish Forecast: Big Lots Staying Small? Views you can use to get clues on the news in advance of Big Lots reports. We already know comps and sales are up, so expectations are high.
The Motley Fool September 21, 2006 Vitaliy Katsenelson	Don't Hit the Panic Button Just Yet Wall Street plays the overreacting game; Walgreen and CVS suffer. These stocks have big tailwinds behind them.
The Motley Fool July 21, 2004 Mike Cianciolo	Is 99 Cents a Good Deal? The discount retailer reported a drop in earnings but has outlined its improvement plans. Despite the positive signs, it's not quite a good buy just yet.
The Motley Fool August 15, 2005 Bobby Shethia	Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors.
The Motley Fool March 28, 2005 Alyce Lomax	A Cool Quarter for Walgreen Are second-quarter earnings putting a damper on Walgreen?
The Motley Fool September 27, 2005 Nathan Slaughter	All Green for Walgreen The retail pharmacy posts record earnings and sales for the 31st consecutive year. Even though Walgreen's latest numbers came up a little short of the mark, it wasn't enough to capture the attention of value investors.
The Motley Fool August 1, 2007 Ryan Fuhrmann	Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one.
The Motley Fool August 10, 2007 Lawrence Rothman	99 Cents Only: Check the Bargain Bin Quarterly earnings from 99 Cents Only Stores boasted strong fundamentals, but investors still discounted the discount chain.
The Motley Fool June 23, 2006 Rich Smith	Foolish Forecast: Walgreen The retail pharmacy reports its fiscal third-quarter 2006 earnings on Monday. Investors -- buy, sell or waffle?
The Motley Fool December 23, 2003 Dave Marino-Nachison	Duane Reade's NY Story The well-known New York drugstore chain is going private after just under six years.
The Motley Fool July 11, 2011	Texas Industries Earnings Preview The supplier of heavy construction materials will unveil its latest earnings on Thursday.
The Motley Fool June 28, 2005 Mike Cianciolo	Just What Investors Prescribed With another quarter of stellar growth at Walgreen, the stock approaches its highest price ever.
The Motley Fool April 9, 2007 Mike Cianciolo	CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note.
The Motley Fool November 3, 2006	CVS Sees Sales Rise: Fool by Numbers The retail pharmacy released third-quarter 2006 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool April 4, 2007 Timothy M. Otte	Walgreen's Comp Machine The drugstore operator steams through March with 8% comparable sales growth. The stock trades at a P/E of 24 times trailing-12-month earnings, about one-third higher than the average of all S&P 500 companies.
BusinessWeek September 19, 2005 Gene G. Marcial	CVS' Ever-Expanding Aisles According to analysts, the aging population and improving pipeline of new drugs will help the retail pharmacy achieve its goal of 15% overall long-term earnings growth. Investors, take note.
The Motley Fool July 18, 2011	Earnings Preview: New York Times New York Times didn't hit the Street's expectations last quarter, but investors hope that it will rebound this quarter, on Thursday, July 21.
The Motley Fool March 24, 2006 Rich Smith	Foolish Forecast: Walgreen Diagnosed Walgreen investors need to keep a close eye on inventory growth to make sure it doesn't outpace sales. Otherwise, those inventories might need to be marked down, or even pitched in the dumpster one day.
The Motley Fool December 11, 2006 Ryan Fuhrmann	Casey's Quarter Isn't Filling Gas is proving not so fulfilling at Casey's General Stores, but check out its long-term prospects. Investors, take note.
The Motley Fool March 26, 2010 Cathy Applefeld Olson	Can CVS Caremark Win the Drug Wars? Now that health-care legislation has been signed into law, it's a perfect time to give the country's largest drugstore chain a checkup.
The Motley Fool September 29, 2010 Andrew Bond	Walgreen Surprises the Experts Walgreen posts a great quarter as competition falters.
The Motley Fool March 26, 2007 Ryan Fuhrmann	Addicted to Growth at Walgreen Walgreen is a steady grower, but that comes at a price. Investors, take note.
The Motley Fool June 9, 2011	Best Buy Earnings Preview Best Buy beat estimates by 12 cents last quarter and investors are hoping it can beat them again.
The Motley Fool September 22, 2006 Ryan Fuhrmann	More in Store at Rite Aid? The retail pharmacy posted strong second-quarter sales, and an acquisition could help long-term results. Investors, take note.
The Motley Fool June 10, 2010 Claire Stephanic	CVS Caremark vs. Walgreen The two go head-to-head in competition for pharmacy customers.
The Motley Fool October 5, 2007 Timothy M. Otte	CVS: Consistently Very Solid The drugstore giant scores a consistent sales increase in September, as it begins to capitalize on synergies from its CareMark acquisition.
The Motley Fool May 4, 2011 Jason Knapp	Generic Drugs and Old People Could Make You Rich CVS hasn't generated market-beating returns yet -- but it will.
The Motley Fool July 3, 2007 Rich Duprey	A Penny Lost, Officially 99 Cents Only catches up on its financial reports. Investors, take note.
The Motley Fool March 6, 2009 Brian Orelli	Don't Let It Go! Health insurer WellPoint is trying to sell its pharmacy business management segment. Is it the right move for them for right now?
The Motley Fool September 27, 2004 Phil Wohl	Walgreen: Prescription for Success The leading drugstore retailer is leveraging prescription sales to produce record results. Fourth-quarter earnings grew to $0.32 per share, which was an 18% improvement over last year's $0.27.
The Motley Fool January 8, 2007 Matthew Crews	CVS' Tightrope Walk The drugstore chain's aggressive growth strategy continues to pay off -- for now. Investors, take note.
The Motley Fool March 23, 2011 Andrew Bond	What More Can You Ask of Walgreen? A sell-off in shares of Walgreen provides a buying opportunity for investors who want in on a best-of-breed company at a discount.
The Motley Fool October 1, 2008 Timothy M. Otte	Walgreen Passes Q4 Physical Slower growth doesn't slow down drugstore giant Walgreen's.
The Motley Fool September 28, 2007 Timothy M. Otte	Foolish Forecast: Walgreen Still Minting the Green? In advance of fourth-quarter earnings, analysts expect the company to continue its record of four straight years of sales growth.
The Motley Fool June 10, 2004 Alyce Lomax	Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition.
The Motley Fool June 29, 2007 Ryan Fuhrmann	Rite Aid's Recent Remedy Will increased market clout lead the drugstore operator to new highs? Investors, take note.